Table 1 Frequency of mutations and histological distribution in cervical cancer.

From: Clinical implication of oncogenic somatic mutations in early-stage cervical cancer with radical hysterectomy

 

All n = 55

SCC n = 36

Non-SCC n = 19

P value

Any mutation n (%)

35 (63.6)

21 (58.3)

14 (73.7)

0.26

PIK3CA n (%)

19 (34.5)

15 (41.7)

4 (21.1)

0.126

KRAS n (%)

5 (9.1)

0 (0)

5 (26.3)

0.003

TP53 n (%)

5 (9.1)

1 (2.8)

4 (21.1)

0.043

PTEN n (%)

4 (7.3)

2 (5.6)

2 (10.5)

0.43

FBXW7 n (%)

3 (5.5)

3 (8.3)

0 (0)

0.272

Back to article page